Head-To-Head Contrast: IceCure Medical (NASDAQ:ICCM) versus Inspire Medical Systems (NYSE:INSP)

IceCure Medical (NASDAQ:ICCM – Get Free Report) and Inspire Medical Systems (NYSE:INSP – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, earnings, valuation, profitability and dividends.

Profitability

This table compares IceCure Medical and Inspire Medical Systems’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
IceCure Medical -439.71% -180.46% -116.68%
Inspire Medical Systems 11.43% 7.32% 6.39%

Institutional & Insider Ownership

0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by insiders. Comparatively, 2.2% of Inspire Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for IceCure Medical and Inspire Medical Systems, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IceCure Medical 1 1 2 0 2.25
Inspire Medical Systems 4 12 3 1 2.05

IceCure Medical currently has a consensus target price of $30.00, indicating a potential upside of 3,647.19%. Inspire Medical Systems has a consensus target price of $71.24, indicating a potential upside of 29.57%. Given IceCure Medical’s stronger consensus rating and higher possible upside, equities research analysts clearly believe IceCure Medical is more favorable than Inspire Medical Systems.

Earnings & Valuation

This table compares IceCure Medical and Inspire Medical Systems”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
IceCure Medical $3.95 million 0.69 -$15.06 million ($7.11) -0.11
Inspire Medical Systems $911.98 million 1.75 $145.42 million $3.44 15.98

Inspire Medical Systems has higher revenue and earnings than IceCure Medical. IceCure Medical is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

IceCure Medical has a beta of 0.57, meaning that its share price is 43% less volatile than the S&P 500. Comparatively, Inspire Medical Systems has a beta of 0.67, meaning that its share price is 33% less volatile than the S&P 500.

Summary

Inspire Medical Systems beats IceCure Medical on 12 of the 15 factors compared between the two stocks.

About IceCure Medical

(Get Free Report)

IceCure Medical Ltd. is an Israel-based medical technology company that develops and commercializes minimally invasive cryoablation systems. Its technology uses liquid nitrogen to freeze and destroy targeted tissue, offering a percutaneous approach to treating tumors. The company’s ProSense system is designed for image-guided cryoablation and is used in procedures involving breast, kidney, lung, bone and other tumors. IceCure also offers the IceSense3 system for treating benign breast fibroadenomas.

About Inspire Medical Systems

(Get Free Report)

Inspire Medical Systems is a medical technology company focused on treatments for obstructive sleep apnea, a condition in which breathing repeatedly stops or becomes restricted during sleep. Founded in 2007 and based in Minnesota, the company develops implantable devices intended for certain patients who cannot use or benefit from conventional positive airway pressure therapy. Its primary product, the Inspire Upper Airway Stimulation system, uses an implanted device to monitor breathing and deliver mild stimulation to the hypoglossal nerve, helping keep the airway open during sleep.

Receive News & Ratings for IceCure Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IceCure Medical and related companies with MarketBeat.com's FREE daily email newsletter.